Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
PLoS One. 2024 Jul 16;19(7):e0307069. doi: 10.1371/journal.pone.0307069. eCollection 2024.
To identify the clinical effect of inspiratory muscle training (IMT) among esophageal cancer patients undergoing esophagectomy based on randomized controlled trials (RCTs).
Several databases were searched for relevant RCTs up to August 23, 2023. Primary outcomes were respiratory muscle function, including the maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP), and pulmonary function, including the forced expiratory volume in one second % (FEV1%), forced vital capacity% (FVC%), maximal ventilator volume (MVV), FEV1/FVC% and FVC. The secondary outcomes were exercise performance, including the six-minute walk distance test (6MWT) and Borg index; mental function and quality of life, as evaluated by the Hospital Anxiety Depression Scale (HADS) and Nottingham Health Profile (NHP) score; and postoperative complications. All the statistical analyses were performed with REVMAN 5.3 software.
Eight RCTs were included in this meta-analysis, with 368 patients receiving IMT and 371 control subjects. The pooled results demonstrated that IMT could significantly enhance respiratory muscle function (MIP: MD = 7.14 cmH2O, P = 0.006; MEP: MD = 8.15 cmH2O, P<0.001) and pulmonary function (FEV1%: MD = 6.15%, P<0.001; FVC%: MD = 4.65%, P<0.001; MVV: MD = 8.66 L, P<0.001; FEV1/FVC%: MD = 5.27%, P = 0.03; FVC: MD = 0.50 L, P<0.001). Furthermore, IMT improved exercise performance (6MWT: MD = 66.99 m, P = 0.02; Borg index: MD = -1.09, P<0.001), mental function and quality of life (HADS anxiety score: MD = -2.26, P<0.001; HADS depression score: MD = -1.34, P<0.001; NHP total score: MD = -48.76, P<0.001). However, IMT did not significantly decrease the incidence of postoperative complications.
IMT improves clinical outcomes, such as respiratory muscle function and pulmonary function, in esophageal cancer patients receiving esophagectomy and has potential for broad applications in the clinic.
基于随机对照试验(RCT),确定食管癌患者术前进行吸气肌训练(IMT)的临床效果。
截至 2023 年 8 月 23 日,检索了多个数据库以寻找相关的 RCT。主要结局指标是呼吸肌功能,包括最大吸气压力(MIP)和最大呼气压力(MEP),以及肺功能,包括一秒钟用力呼气量占预计值的百分比(FEV1%)、用力肺活量占预计值的百分比(FVC%)、最大通气量(MVV)、FEV1/FVC%和 FVC。次要结局指标是运动表现,包括 6 分钟步行距离试验(6MWT)和 Borg 指数;心理功能和生活质量,采用医院焦虑抑郁量表(HADS)和诺丁汉健康调查问卷(NHP)评分评估;以及术后并发症。所有的统计分析均使用 REVMAN 5.3 软件进行。
这项荟萃分析纳入了 8 项 RCT,其中 368 例患者接受了 IMT,371 例患者接受了对照组治疗。汇总结果表明,IMT 可显著增强呼吸肌功能(MIP:MD=7.14cmH2O,P=0.006;MEP:MD=8.15cmH2O,P<0.001)和肺功能(FEV1%:MD=6.15%,P<0.001;FVC%:MD=4.65%,P<0.001;MVV:MD=8.66L,P<0.001;FEV1/FVC%:MD=5.27%,P=0.03;FVC:MD=0.50L,P<0.001)。此外,IMT 还改善了运动表现(6MWT:MD=66.99m,P=0.02;Borg 指数:MD=-1.09,P<0.001)、心理功能和生活质量(HADS 焦虑评分:MD=-2.26,P<0.001;HADS 抑郁评分:MD=-1.34,P<0.001;NHP 总分:MD=-48.76,P<0.001)。然而,IMT 并未显著降低术后并发症的发生率。
IMT 可改善食管癌患者术前的呼吸肌功能和肺功能等临床结局,具有广泛的临床应用潜力。